24/7 Support • Copay Assistance • Nationwide Delivery • 917-830-2525
Zortress is the brand name for everolimus (transplant dose), an mTOR inhibitor FDA-approved in April 2010 to prevent organ rejection in adult kidney transplant recipients, with liver transplant added in 2013, for patients at low-to-moderate immunologic risk. Zortress is manufactured by Novartis Pharmaceuticals. QuickRx dispenses generic everolimus for transplant patients and coordinates the financial-assistance programs that offer the best savings on your therapy.
Our everolimus financial assistance includes:
✚ Foundation grant application support to help cover out-of-pocket costs
✚ Patient assistance program coordination for Medicare, Medicaid, and uninsured patients
✚ Medicare Part B guidance for transplant immunosuppressant coverage
✚ Insurance benefit verification and prior authorization support
✚ Home delivery and ongoing refill coordination
Our team is dedicated to eliminating financial barriers so you can focus on your recovery and long-term transplant health. Contact QuickRx today to learn how we can help reduce your everolimus costs.
QuickRx provides comprehensive support for transplant patients prescribed everolimus (Zortress) to help lower their medication costs:
✓ Foundation grant coordination
✓ Personalized program matching
✓ Insurance and Medicare coordination
✓ Nationwide home delivery
Commercially insured patients may qualify for the Novartis Universal Co-Pay Card that significantly reduces out-of-pocket costs. QuickRx handles the entire Zortress copay card application process, and eligible patients may pay $0.
For Medicare, Medicaid, and uninsured patients, QuickRx coordinates access to the Novartis Patient Assistance Foundation and other programs specifically designed for oncology medications like zortress (everolimus).
Getting started takes just minutes. Call (917) 830-2525 or complete our online form, and a QuickRx specialist will contact you within 24-48 hours to discuss your everolimus copay assistance options.
Getting started takes just minutes. Call (917) 830-2525 or complete our online form, and a QuickRx specialist will contact you within 24-48 hours to discuss your everolimus copay assistance options.
Complete the secure form below to begin your everolimus (Zortress) copay assistance application. A QuickRx patient navigator will contact you within one business day to discuss your options and guide you through the enrollment process.
Prefer to speak with someone directly?
Call Us for Immediate Assistance:
Main: (917) 830-2525
Your information is protected under HIPAA privacy regulations. QuickRx Specialty Pharmacy is committed to maintaining the confidentiality of your personal health information.
Zortress is the brand name for everolimus, an mTOR inhibitor used to prevent organ rejection after a kidney or liver transplant. It is prescribed for adult transplant recipients at low-to-moderate immunologic risk and is taken alongside other immunosuppressant medications.
Everolimus lowers the activity of the immune system so your body is less likely to attack the transplanted organ. It is given in combination with a calcineurin inhibitor (cyclosporine or tacrolimus) and corticosteroids, with regular blood-level monitoring to keep the dose in the right range. Learn more about post-transplant immunosuppression from the NIH.
Zortress and generic everolimus contain the same active ingredient at the same transplant strengths. QuickRx dispenses generic everolimus for transplant patients and helps you access copay and financial assistance to keep your medication affordable. Call (917) 830-2525 to learn more.
Yes. QuickRx dispenses generic everolimus for transplant patients and coordinates the financial-assistance programs that lower your out-of-pocket medication costs. Generic everolimus contains the identical active ingredient as brand-name Zortress and meets the same FDA standards for safety and effectiveness.
QuickRx does not issue manufacturer copay cards; we facilitate enrollment in programs funded by manufacturers or independent foundations. Learn more about generic drugs from the FDA.
Call (917) 830-2525 to get started with QuickRx.
Generic everolimus for transplant is far less expensive than brand-name Zortress, though it is still a specialty medication. Published cash-price references for generic everolimus transplant-dose tablets run from a few hundred dollars to roughly $1,700 for a 60-tablet supply as of 2026, depending on strength and pharmacy. Brand-name Zortress typically costs considerably more.
QuickRx provides all financial-assistance services completely free of charge. Call (917) 830-2525 to find out how much you could save on everolimus.
Pricing shown is an approximate cash-price range compiled from publicly available drug-price references as of 2026 and is provided for general educational purposes only. Actual costs vary by dose, pharmacy, insurance, and region, and change over time. For prescribing information, see the official FDA Zortress label. This is not a quote or guarantee of price.
Yes, generic everolimus is available in transplant strengths, and QuickRx dispenses it. Generic everolimus contains the same active ingredient as brand-name Zortress and offers significant cost savings.
Generic everolimus for transplant is available in 0.25 mg, 0.5 mg, 0.75 mg, and 1 mg tablets from multiple manufacturers. Your transplant team and pharmacist determine the strength and dosing that is right for you based on your blood-level monitoring.
QuickRx dispenses generic everolimus for transplant patients. Call (917) 830-2525 to discuss your options.
Transplant patients can lower their everolimus costs through foundation grants, patient assistance programs, and insurance coordination, and QuickRx handles all of it at no charge. Even as a generic, everolimus is a specialty medication, so financial assistance can make a meaningful difference.
Our patient navigators research every program you may qualify for, complete the applications on your behalf, and monitor for grant openings so you don’t miss a funding window. Eligible patients may pay $0. Call (917) 830-2525 to find out what you qualify for.
Yes. Most transplant patients are on Medicare, and there are several ways to reduce everolimus costs, though Medicare patients cannot use manufacturer copay cards due to federal regulations. QuickRx helps Medicare patients navigate the assistance options available to them.
Transplant immunosuppressant drugs may be covered under Medicare Part B in certain circumstances following a Medicare-covered transplant, which is different from how most prescription drugs are covered under Part D. Coverage rules are specific and depend on your individual situation. Learn more directly from Medicare.gov on immunosuppressive drug coverage.
QuickRx patient navigators help you understand which coverage applies to you and coordinate assistance accordingly. Call (917) 830-2525 to discuss Medicare options for everolimus.
Several independent charitable foundations offer grants that help transplant patients cover the cost of immunosuppressant medications like everolimus. These foundations are separate from drug manufacturers and open and close funding periodically as money becomes available.
Because grant funds can open and close quickly, timing matters. QuickRx patient navigators actively monitor foundation openings, complete applications the moment funds become available, and manage renewals so your assistance continues. Call (917) 830-2525 to have QuickRx track grant opportunities for you.
No, QuickRx financial-assistance services are always 100% FREE to patients. We never charge for helping you enroll in patient assistance programs or foundation grants for your everolimus.
As a specialty pharmacy, QuickRx is reimbursed through normal pharmacy dispensing, so we don’t need to charge patients separately for financial-assistance services. Our goal is to help as many transplant patients as possible access their everolimus affordably.
Ready to get started? Call (917) 830-2525 or complete our online form for free everolimus copay assistance.
Everolimus for transplant is typically taken twice daily by mouth, at doses much lower than those used for cancer. Following your dosing schedule precisely is essential to protect your transplanted organ.
Your transplant team checks your everolimus whole-blood trough levels regularly and adjusts your dose to keep it in the target range. Never change your dose on your own. Avoid grapefruit and grapefruit juice, which can raise everolimus levels.
QuickRx pharmacists are available to answer questions about taking everolimus correctly. Call (917) 830-2525.
If you miss a dose of everolimus, contact your transplant team for guidance, and never take two doses at once to make up for a missed one. Keeping your blood levels steady is critical for protecting your transplanted organ, so consistency matters more here than with many other medications.
If you frequently miss doses or have questions about your schedule, contact your healthcare provider or call QuickRx at (917) 830-2525.
Everolimus interacts with many medications, which is especially important for transplant patients who often take several drugs at once. Everolimus is processed by the CYP3A4 enzyme and the P-glycoprotein transporter, so drugs that affect these systems can raise or lower your everolimus levels. Always tell your doctor and pharmacist about everything you take.
Some combinations should be avoided entirely, so a full pharmacist review matters. QuickRx pharmacists review your complete medication list for interactions with everolimus. Call (917) 830-2525 to speak with a pharmacist.
Regular lab monitoring is required while taking everolimus, including everolimus blood-level testing that is central to transplant dosing. Your transplant team schedules these tests to keep your dose in the right range and to watch for side effects.
Report any signs of infection, breathing problems, or unusual symptoms between visits. Questions about monitoring? Call (917) 830-2525 to speak with a QuickRx pharmacist.
Common side effects of everolimus include mouth sores, increased risk of infection, swelling, high blood sugar, and changes in cholesterol. Because everolimus lowers immune activity to protect your transplant, infection risk is an important consideration. Your transplant team monitors you throughout treatment.
Contact your healthcare provider immediately if you experience serious side effects. QuickRx pharmacists are also available at (917) 830-2525.
Everolimus prevents organ rejection by inhibiting the mTOR protein, which reduces the activity of immune cells that would otherwise attack the transplanted organ. This targeted immunosuppression helps your body accept the new organ.
The mTOR (mammalian target of rapamycin) protein helps drive the growth and multiplication of certain immune cells. By binding to a protein called FKBP-12 and inhibiting mTOR, everolimus slows the proliferation of the T-cells and other immune cells involved in rejection. Learn more about kidney transplantation from the NIH.
Everolimus is used together with a calcineurin inhibitor (cyclosporine or tacrolimus) and corticosteroids. Combining agents that work in different ways provides more complete protection against rejection while allowing each drug to be used at a carefully monitored dose.
Everolimus should not be taken during pregnancy, as it can harm an unborn baby. Women who could become pregnant should use effective contraception during treatment and for a period after stopping, and should discuss family planning with their transplant team.
Family planning is especially important for transplant patients, since managing pregnancy alongside immunosuppression requires specialist coordination. Discuss any pregnancy plans with your transplant team before making changes.
Proper storage of everolimus helps ensure the medication stays effective throughout your treatment. Follow these storage guidelines carefully.
Ask your pharmacist about proper disposal methods or FDA-approved drug take-back programs. Learn more about safe medication disposal from the FDA.
Questions about storing your everolimus? Call QuickRx at (917) 830-2525.
Zortress and Afinitor both contain everolimus, but they are used for entirely different purposes and at different doses. Understanding the difference helps ensure you get the right assistance for your situation.
Zortress is the lower-dose everolimus used to prevent organ rejection after a kidney or liver transplant. It is dosed twice daily and adjusted based on blood-level monitoring, and it is taken alongside other immunosuppressants.
Afinitor is the higher-dose everolimus used to treat certain cancers and tuberous sclerosis complex (TSC), typically dosed once daily. If you were prescribed everolimus for cancer or TSC, see our Afinitor (everolimus) copay assistance page. For a side-by-side overview, see our guide on the differences between Afinitor and Zortress.
QuickRx dispenses generic everolimus for transplant patients. Call (917) 830-2525 to discuss copay assistance.
Before starting everolimus, share your complete medical history with your transplant team. This helps ensure everolimus is safe for you and allows your team to monitor for potential complications.
Bring a complete list of all prescription drugs, over-the-counter medicines, vitamins, and herbal supplements, since many products interact with everolimus. QuickRx pharmacists can help review your list. Call (917) 830-2525.
QuickRx Specialty Pharmacy provides comprehensive support for transplant patients taking everolimus, combining expert pharmacy services with dedicated financial-assistance help. We’re committed to making your treatment as affordable and convenient as possible.
QuickRx is a nationwide specialty pharmacy licensed in all 50 states. We understand that recovering from a transplant is challenging enough without worrying about medication costs. Our team is here to help you access the everolimus you need at the lowest possible cost.
Ready to get started? Call (917) 830-2525 to speak with a patient navigator today.
This page is provided for general educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. It does not cover all possible uses, dosages, precautions, drug interactions, or side effects of everolimus (Zortress). Transplant immunosuppression is highly individualized, and dosing is guided by blood-level monitoring under the care of your transplant team.
Always consult your physician, transplant team, or pharmacist before starting, stopping, or changing any medication. Never adjust your everolimus dose on your own. If you think you may have a medical emergency, call your doctor or 911 immediately.
QuickRx Specialty Pharmacy dispenses generic everolimus for transplant patients and provides free financial-assistance coordination. QuickRx does not issue manufacturer copay cards; QuickRx facilitates enrollment in programs funded by manufacturers or independent foundations. Eligibility for any assistance program is determined by the program sponsor, and enrollment is not guaranteed. Any pricing referenced is an approximate figure compiled from publicly available sources as of 2026, is provided for educational purposes only, and is not a quote or guarantee of price.
"*" indicates required fields